Changes in circulating MOTS-c levels failed to reach statistical significance when comparing patients achieving pathological complete response (pCR), irrespective of metformin treatment.
← all excerpts
Circulating levels of MOTS-c in patients with breast cancer treated with metformin.
1
—
—